At a glance
ClinicalIndex Comparison RecordN/ACompleted· 548 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients Based on Body Compositions Measured by 3D CT Scan and Hematological Indicators
In Brief
An observational study evaluating no intervention for Pancreatic Cancer. Completed, enrolled 548 participants across 1 site.
Detailed Summary
By evaluating the nutritional status of patients with pancreatic ductal adenocarcinoma (PDAC) admitted to Jinling Hospital, collecting relevant clinical data. we aim to conduct correlation analysis with patient clinical information, such as survival time, hospitalization time, nutritional status, hematological indicators, etc., in order to reveal the prognostic factors for overall survival and postoperative complications of PDAC patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJan 2019
Primary CompletionDec 2023
Study CompletionFeb 2024
First PostedApr 2024
TodayJul 2026
First PostedApr 23, 2024
Enrollment StartJan 1, 2019
Primary CompletionDec 31, 2023
Study CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 2.2 years ago
Interventions
no interventionother
no intervention